Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
Las Vegas, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a...
Concussion
Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team
Las Vegas, Nevada, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the...
Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device
Las Vegas, Nevada, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the...
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Neurobehavioral Outcomes in a Model of Traumatic Brain Injury
Pre-clinical trial demonstrates ability of nVNS to decrease amount of brain injury, decrease anxiety and improve motor function post injuryROCKAWAY,...
Odyssey Health, Inc. Forms Pharmaceutical Subsidiary Focused on Treating Neurological Diseases
Las Vegas, Nevada, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a...
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug
Las Vegas, Nevada, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a...
New Study Reveals Effective Treatment for Children Suffering From Persistent Post-Concussion Syndrome
Study shows that hyperbaric oxygen therapy significantly improves symptoms, including memory, emotional and behavioral, and heals brain structure in cortical...
Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II
Las Vegas, NV, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a...
SyncThink Secures CE Mark for EYE-SYNC Digital Health Platform
Neurotechnology solution gains vital certification needed for EU expansion Palo Alto, CA – (August 10, 2022) – SyncThink, a next generation...
Odyssey Health, Inc. Launches New Corporate Website
Odyssey Health, Inc. Launches New Corporate Website $ODYY - Odyssey Health, Inc. - New Corporate WebsiteLas Vegas, NV, Aug. 04,...
Top Neurology and Chiropractic Clinicians Adopt EYE-SYNC
North Boulder Chiropractic and Restoration Neurology Onboard EYE-SYNC technology to improve patient care with objective data Palo Alto, CA—October 7,...
Premier Lacrosse League Partners with SyncThink, Brings Objective Data to Player Brain Health and Performance
Stamford, CT --May 29, 2019--The Premier Lacrosse League (PLL), America’s first professional field lacrosse league featuring the top 160 male...
NeuroSport™ Onboards EYE-SYNC from SyncThink for Athlete Brain Health Evaluations, Concussion Management and Performance
Palo Alto, CA and Deerfield Beach, FL--May 21, 2019—NeuroSport™, a state-of-the-art concussion assessment, treatment, prevention and ‘return to play’ services...